Recognizing, understanding, and treating critical community acquired methicillin-resistant Staphylococcus aureus infection in children

Pediatric Critical Care Medicine

Volumn 10, Issue 3, 2009, Pages 405-407

  Carcillo, Joseph A ^a   Castillo, Leticia ^b   Thomas, James ^c   Kissoon, Niranjan ^d  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d BC CHILDREN S HOSPITAL   (Canada)

Author keywords

MRSA; Pneumonia; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; CLINDAMYCIN; DAPTOMYCIN; DOXYCYCLINE; GENTAMICIN; IMMUNOGLOBULIN; LINEZOLID; RIFAMPICIN; SULFAMETHOXAZOLE; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; DEBRIDEMENT; DISEASE ASSOCIATION; DISEASE CONTROL; EDITORIAL; EPIDEMIC; HUMAN; INFLUENZA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIXED INFECTION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; CHILD; COMMUNICABLE DISEASE; DRUG COMBINATION; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; NOTE; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 68849092128     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181a33038     Document Type: Editorial

References (12)

1. Creel AM, Durham SH, Benner KM, et al: Severe invasive community-associated me-thicillin-resistant Staphylococcus aureus infections in previously healthy children. Pediatr Crit Care Med 2009; 10:323-327
2. Gonzalez BE, Hulten KG, Dishop MK: Pulmonary manifestations in children with invasive community acquired Staphylococcus aureus infection. Clin Infect Dis 2005; 41:583-590
3. Odetola FO, Gebremariam A, Freed GL: Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics 2007; 119:487-494
4. Nathwani D, Morgan M, Masterton RG, et al: Guidelines for UK practice for the diagnosis and management of methicillin resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008; 61:976-994
5. Carcillo JA, Fields AI; ACCM Task Force Committee Members: Clinical practice parameters for hemodynamic support of pediatric and neonatal patient in septic shock. Crit Care Med 2002; 30:1365-1378
6. Prechter GC, Gerhard AK: Postinfluenza toxic shock syndrome. Chest 1989; 95: 1153-1154
7. Yanagisawa C, Hanaki H, Natae T, et al: Neutralization of staphylococcal exotoxins in vitro by human origin intravenous immuno-globulin. J Infect Chemother 2007; 123: 368-372
8. Gauduchon V, Cozon G, Vandenesch F, et al: Neutralization of Staphylococcus aureus Panton-Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 2004; 189:346-353
9. Tseng MH, Wei BH, Lin WJ, et al: Fatal sepsis and necrotizing pneumonia in a child due to community acquired methicillin resistant Staphylococcus aureus: Case report and literature review. Scand J Infect Dis 2005; 37: 504-537
10. Gillet Y, Vanhems P, Lina G, et al: Factors predicting mortality in necrotizing community acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007; 45: 315-321
11. Fortenberry JD, Paden ML: Extracorporeal therapies in the treatment of sepsis: Experience and promise. Semin Pediatr Infect Dis 2006; 17:72-79
12. Creech CB, Johnson BG, Bartilson RE, et al: Increasing use of extracorporeal life support in methicillin resistant Staphylococcus au-reus sepsis in children. Pediatr Crit Care Med 2007; 8:294-296